The bisphosphonate dilemma.
Koyano
H
H
Schimizu
T
T
Shishiba
Y
Y
D019386:Alendronate; D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000556:secondary; D001842:Bone and Bones / Q000000981:diagnostic imaging*; D004002:Clodronic Acid / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use*; D005188:False Negative Reactions; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy / Q000209:etiology; D008875:Middle Aged; D010282:Parathyroid Neoplasms / Q000473:pathology; D011877:Radionuclide Imaging; D013669:Technetium Tc 99m Medronate / Q000031:analogs & derivatives*
D004164:Diphosphonates; D004002:Clodronic Acid; C024226:technetium Tc 99m hydroxymethylene diphosphonate; D019386:Alendronate; D013669:Technetium Tc 99m Medronate